Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal melanoma

Jeffim N. Kuznetsoff, Dawn A. Owens, Andy Lopez, Daniel A. Rodriguez, Nancy T. Chee, Stefan Kurtenbach, Daniel Bilbao, Evan R. Roberts, Claude Henry Volmar, Claes Wahlestedt, Shaun P. Brothers, J. William Harbour

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences